AzTrials
AzTrials

Health BehaviorNCT07389317

Assessing Illustrated Medication Labels

A study testing standard medication label and Illustrated medication label in people with Health Behavior and Medication Adherence, run by Wayne Sanderson at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to evaluate the impact of graphic-based medication labels on medication understanding and to assess the health literacy of our farmworker population. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
standard medication label and Illustrated medication label
Could I receive a placebo?
No, everyone receives an active treatment
How many people
87 participants
Where
2 sitesUnited States
Study dates
17 May 2025to 22 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Adults aged 18 and older
  • Receiving medication education at Emory Farm Worker Project (EFP) clinics

Who cannot join

  • Individuals unable to provide informed consent or participate in the study
  • Those not requiring medication during their visit

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Emory University

    Atlanta, Georgia, 30322

  • University of Kentucky

    Lexington, Kentucky, 40506

Other trials in United States

About this study

Official title: Assessing the Impact of Illustrated Medication Labels on Medication Understanding Among Migrant and Seasonal Farmworkers in South Georgia

The goal of this clinical trial is to evaluate the impact of graphic-based medication labels on medication understanding and to assess the health literacy of our farmworker population. The main questions it aims to answer are:

Primary Objective: Assess the impact of illustrated medication labels on medication understanding among migrant and seasonal farmworkers Secondary Objective: Evaluate the health literacy of the farmworker population in South Georgia

Participants will be given either medication labels with pictures or standard medication labels

Being tested
standard medication label, Illustrated medication label
Medical subject headings
Health Behavior, Medication Adherence

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • standard medication labelBehavioural

    Standard Education Procedure: Based on best practices, including simple, standardized instructions in the participants' native language and the "teach-back" method.

  • Illustrated medication labelBehavioural

    Illustrated medication labels: Labels will include visuals for medication name, time of administration, food interactions, indications, and potential side effects

Study groups in NCT07389317
Study groupRoleWhat they receive
Standard medication labelActive comparatorNot described
Receives: Behavioral: standard medication label
Illustrated medication labelExperimentalNot described
Receives: Behavioral: Illustrated medication label

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Medication Understanding Questionnaire (MUQ)

    MUQ will assess participants' understanding of their medications after education. Scores range from 0-3 to test medication purpose, dose, and frequency

    Measured: Post intervention (10 minutes)

Secondary outcomes (1)
  1. Brief Health Literacy Screen (BHLS)

    The BHLS consists of 4 questions with each item being worth 1-5 points. Total score range from 4-20 with higher score equating to greater health literacy

    Measured: Post intervention (10 minutes)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Feb 2026
  2. Study start17 May 2025
  3. Primary completion22 May 2025
  4. Study completion22 May 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
87 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07389317
Sponsor's protocol ID
105049
Other IDs
U54OH007547
Status last verified
Dec 2025
First submitted
23 Jan 2026
Last updated
5 Feb 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing standard medication label and Illustrated medication label in people with Health Behavior and Medication Adherence, run by Wayne Sanderson at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Medication Understanding Questionnaire (MUQ) (time frame: Post intervention (10 minutes)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Feb 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in